← Back to Patent Explorer
US4542015A Expired / Lapsed US ⏱️ 0.0 years remaining

Dialysis apparatus and process for controlling the phosphate level of blood

Assignee: COBE NEPHROSS BV
•
Filing: 1982-08-19
•
Granted: 1985-09-17
•
Expires: 2002-08-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An apparatus for purifying blood has a blood compartment and a clearance compartment separated by a semi-permeable membrane. The apparatus includes a device containing a cation exchange resin charged with metal ions whose phosphates are insoluble in water. Metal salts of iron, aluminum, zirconium, lanthanum, thorium and tin are deposited on a cation exchange material and the charged cation exchange resin is contacted with dialysis liquid. The process of treating blood with the dialysis liquid is also contemplated.

Inventors

  • 👤 Robert Smakman
  • 👤 Gerrit H. van den Berg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 06:47
CPC Classifications
A; A61; A61K; A61K33/00; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/58; A61K47/585; A61M; A61M1/00; A61M1/14; A61M1/16; A61M1/1694; A61M1/1696; A61M1/36; A61M1/3679; B; B01; B01J; B01J39/00; B01J39/04; B01J39/05; B01J39/07; B01J39/08; B01J39/16; B01J39/18; B01J39/20; B01J41/00; B01J41/04; B01J41/05

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 57 words
In a method for the preparation of a cation exchanger charged with metal ions adapted for controlling the phosphate level in blood by oral administration, the steps which comprise charging a cation exchanger with from 10% to 100% alkali metal ions before or after it is charged with ions of iron (III), tin, lanthanum, aluminum or zirconium.
Claim 2
Dependent Claim 57 words
In a method for the preparation of a cation exchanger charged with metal ions adapted for controlling the phosphate level in blood by oral administration, the steps which comprise charging a cation exchanger with from 10% to 100% alkali metal ions before or after it is charged with ions of iron (III), tin, lanthanum, aluminum or zirconium.
Claim 3
Dependent Claim 27 words
The method of claim 1, wherein the said alkali metal ions are sodium and the said metal ions which react with phosphate ions are iron III ions.
Claim 4
Dependent Claim 28 words
A phosphate sorbent for oral administration capable of controlling the phosphate level in blood comprising an organic cation exchanger charged with ferric ions in a pharmaceutically acceptable carrier.
Claim 5
Dependent Claim 28 words
A phosphate sorbent for oral administration capable of controlling the phosphate level in blood comprising an organic cation exchanger charged with ferric ions in a pharmaceutically acceptable carrier.
Claim 6
Dependent Claim 14 words
A phosphate sorbent according to claim 3 comprising a weakly acid organic cation exchanger.
Claim 7
Dependent Claim 20 words
The phosphate sorbent of claim 4 wherein the cation exchanger contains carboxylic acid groups, phosphonic acid groups or amidoxime groups.
Claim 8
Dependent Claim 17 words
The phosphate sorbent of claim 5 wherein the cation exchanger contains aminocarboxylic acid or iminodicarboxylic acid groups.
Claim 9
Dependent Claim 17 words
The phosphate sorbent of claim 5 wherein the cation exchanger contains aminoacetic acid or iminodiacetic acid groups.
Claim 10
Dependent Claim 16 words
The phosphate sorbent of claim 3 wherein the cation exchanger is a strongly acid cation exchanger.
Claim 11
Dependent Claim 16 words
The phosphate sorbent of claim 3 wherein the cation exchanger has a high degree of cross-linking.
Claim 12
Dependent Claim 14 words
The phosphate sorbent of claim 8 wherein the cation exchanger contains sulphonic acid groups.
Claim 13
Dependent Claim 32 words
The phosphate sorbent of claim 3 wherein the cation exchanger has a matrix comprising a polymer or a polycondensation product of an aromatic compound, an acryl, a methacryl or a vinyl compound.
Claim 14
Dependent Claim 14 words
The phosphate sorbent of claim 3 wherein the cation exchanger has a macroporous matrix.
Claim 15
Dependent Claim 14 words
The phosphate sorbent of claim 3 wherein the cation exchanger contains alkali metal ions.
Claim 16
Dependent Claim 14 words
The phosphate sorbent of claim 13 wherein the alkali metal ions are sodium ions.
Claim 17
Dependent Claim 20 words
The phosphate sorbent of claim 13 wherein the cation exchanger contains calcium or magnesium ions and the alkali metal ions.
Claim 18
Dependent Claim 19 words
The phosphate sorbent of claim 3 wherein the pharmaceutically acceptable carrier is a capsule having a cationic semipermeable wall.

References Cited (Backward Citations)

US3012937A Cited
US3079428A Cited
US3501401A Cited
US3947572A Cited
GB2070032A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-09-16 1989-03-18 1989-09-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-09-16 1993-03-18 1993-09-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-09-16 1997-03-18 1997-09-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag